National Differences in Requirements for Ethical and Competent Authority Approval for a Multinational Vaccine Trial under the EU Directive 2001/20/EC

by Eva van Doorn, Eelko Hak, Bob Wilffert
Published 2015-04-01

Meta-Analysis on Randomized Controlled Trials of Vaccines with QS-21 or ISCOMATRIX Adjuvant: Safety and Tolerability.

by Emilia Bigaeva, Eva van Doorn, Heng Liu, Eelko Hak
Published 2016-01-01

Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center,...

by Eva van Doorn, Olga Pleguezuelos, Heng Liu, Ana Fernandez, Robin Bannister, Gregory Stoloff, Fredrik Oftung, Stephen Norley, Anke Huckriede, Henderik W. Frijlink, Eelko Hak
Published 2017-04-01

Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.

by Maryam Darvishian, Frederika Dijkstra, Eva van Doorn, Maarten J Bijlsma, Gé A Donker, Marit M A de Lange, Laura M Cadenau, Eelko Hak, Adam Meijer
Published 2017-01-01